Revive Therapeutics Ltd C.RVV

Catalysts In Q1

[iTrader2K]

I've been bearish on Revive for the past few months as I view our success to be almost entirely rolled up in Bucillamine. Do you guys think any of the milestones listed in the investor deck have the potential to reverse our trend and significantly move the needle? Thus far our last positive PR shot us up temporarily, but we suffered immensely after failing to hold gains for more than 1 trading day. GL my friends

[1ottrunner]

RVV suffered this last down turn with about 80% of every other stock on the market.  These highly speculative and very risky biotechs normally get hammered with the market x2. If you are in this hoping on trial positive results I have some bad news for you.  Getting a great P value in a trial is not an easy thing to do.  This is why biotechs have such great reward when they are